Cargando…
Reponse to Comments on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
Autores principales: | Butler, Alexandra E., Campbell-Thompson, Martha, Gurlo, Tatyana, Dawson, David W., Atkinson, Mark, Butler, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781463/ https://www.ncbi.nlm.nih.gov/pubmed/24065800 http://dx.doi.org/10.2337/db13-0996 |
Ejemplares similares
-
Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Heine, Robert J., et al.
Publicado: (2013) -
Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Engel, Samuel S., et al.
Publicado: (2013) -
Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
por: Butler, Alexandra E., et al.
Publicado: (2013) -
Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes
por: Nomoto, Hiroshi, et al.
Publicado: (2019) -
Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
por: Butler, P. C., et al.
Publicado: (2009)